The Company's ordinary shares are listed on AIM, a market operated by the London Stock Exchange, under the symbol “AREC”. The Company is not listed on any other exchanges or trading platforms.

View

Arecor Therapeutics plc Form of Proxy

23 July 2024

View

Arecor Therapeutics plc Notice of General Meeting

23 July 2024

View

Arecor Therapeutics plc Annual Report and Accounts 2023

31 May 2024

Significant shareholders

BGF Investment Management Limited

13.66%

Lombard Odier Asset Management Limited

8.12%

Unilever*

7.76%

Calculus Capital Ltd

6.37%

Chelverton Asset Management*

4.61%

Velan Capital

4.41%

The Wood family*

4.36%

Oxford Technology VCT*

4.22%

Stewart Newton

4.15%

Thames Ventures Healthcare Ventures and Downing Healthcare Intensive EIS fund

3.67%

Albion Capital Funds*

3.28%

Unicorn AIM VCT

3.18%

The number of shares in issue: 37,756,601
Percentage of shares not in public hands: c. 18.82%
Last reviewed and updated: 31 March 2025


* Total numbers are the aggregate amounts held

**The percentage shareholdings set out above are as far as the Directors are aware and are based on analysis of the Company’s shareholder register as carried out by the Company’s broker and on TR1 notifications as received by the Company directly from shareholders.

Constitutional Documents

Date Title View

2 June 2021

Articles of Association

1 June 2021

Admission Document